Lakewood-Amedex Biotherapeutics, Inc.
Lakewood-Amedex Biotherapeutics, Inc. (LABT) — Form 8-K: Current report
About this filing
Lakewood-Amedex Biotherapeutics, Inc. (LABT) filed an 8-K on Sep 28, 2026 reporting shareholder vote results (Item 5.07).
Key facts
- Item 5.07 · Shareholder vote results
More LABT filings
- EFFECT
Filed Sep 24, 2026
- S-1
Filed Sep 18, 2026
- DRS
Filed Aug 21, 2026
- 424B3
Filed Aug 17, 2026
- SC 13G
Filed Aug 14, 2026
- 10-Q
Filed Aug 13, 2026
Not investment advice. Summaries can contain errors; the SEC filing is the official record.